Compass Pathways (CMPS) PT Raised to $22 at B.Riley
Tweet
Share
E-mailGet Alerts CMPS Hot Sheet
Price: $14.04 --0%
Rating Summary:
19 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
19 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
B.Riley analyst Madison El-Saadi raised the price target on Compass Pathways (NASDAQ: CMPS) to $22.00 (from $17.00) while maintaining a Buy rating.
You May Also Be Interested In
- Compass Pathways reports 52-week Phase 3 trial results for psilocybin TRD drug
- UBS Upgrades China Mobile Ltd (600941:CH) (CHL) to Buy
- BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
